The effect of standard treatments in COPD patients without maintenance therapy.
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000005188
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
A known hypersensitivity to the components of each standard drug for COPD. Known diseases which contraindicate using the standard drugs for COPD according to the package insert. Patients who are judged not to be included in the study by investigator based on a preliminary clinical examination. Not able to follow an instruction for a smoking cessation. A history of asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease. Not able to perform pulmonary function tests. Participation in another trial with an investigational drug within 2 month prior to informed consent visit. Pregnant or nursing women or women of childbearing potential who are not using a medically approved means of contraception.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of pulmonary function (trough FEV1 and trough FVC)
- Secondary Outcome Measures
Name Time Method